Impax Appeals Prilosec Case To Federal Circuit

Law360, New York (July 18, 2007, 12:00 AM EDT) -- A maker of generic pharmaceuticals has appealed a district court's judgment that it infringed several claims of two patents held by AstraZeneca AB related to gastric acid-inhibiting drug Prilosec.

Impax Laboratories Inc. announced on July 10 that it was appealing the judge's ruling on its motion to dismiss those charges as well as her judgment on infringement to the U.S. Court of Appeals for the Federal Circuit, which has subject matter jurisdiction over patent appeals.

On July 5, Judge Barbara S. Jones of the U.S. District...
To view the full article, register now.